Atlas Trials

Yazeed Sawalha

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yazeed Sawalha

RecordFirmDate
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NCT06536049)Yazeed Sawalha2025-04-02
Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma (NCT04635683)Yazeed Sawalha2022-09-30
Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma (NCT04850495)Yazeed Sawalha2021-11-16

Track Yazeed Sawalha automatically

Every clearance here is in the API, with alerts when new ones post.